Your browser is no longer supported. Please, upgrade your browser.
Settings
GNMK GenMark Diagnostics, Inc. daily Stock Chart
GNMK [NASD]
GenMark Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.86 Insider Own4.50% Shs Outstand60.83M Perf Week-2.37%
Market Cap301.11M Forward P/E- EPS next Y-0.60 Insider Trans-5.27% Shs Float56.00M Perf Month-8.84%
Income-48.60M PEG- EPS next Q-0.16 Inst Own92.70% Short Float3.00% Perf Quarter-11.45%
Sales80.20M P/S3.75 EPS this Y25.00% Inst Trans0.00% Short Ratio5.75 Perf Half Y-19.64%
Book/sh0.15 P/B33.00 EPS next Y25.90% ROA-53.80% Target Price9.83 Perf Year-16.81%
Cash/sh0.55 P/C9.07 EPS next 5Y- ROE-239.20% 52W Range4.47 - 8.37 Perf YTD2.91%
Dividend- P/FCF- EPS past 5Y1.00% ROI-68.90% 52W High-40.86% Beta1.15
Dividend %- Quick Ratio2.10 Sales past 5Y20.90% Gross Margin30.90% 52W Low10.74% ATR0.24
Employees477 Current Ratio2.70 Sales Q/Q32.30% Oper. Margin-54.50% RSI (14)46.73 Volatility5.93% 4.62%
OptionableYes Debt/Eq0.00 EPS Q/Q-2.80% Profit Margin-60.60% Rel Volume0.92 Prev Close4.96
ShortableYes LT Debt/Eq5.66 EarningsFeb 05 AMC Payout- Avg Volume292.00K Price4.95
Recom1.70 SMA20-0.27% SMA50-6.75% SMA200-19.92% Volume267,485 Change-0.20%
Dec-11-19Downgrade JP Morgan Overweight → Neutral
Feb-22-19Reiterated Needham Buy $12
Nov-03-17Reiterated Needham Buy $15 → $11
Nov-03-17Downgrade Raymond James Outperform → Mkt Perform
Sep-18-17Initiated BofA/Merrill Buy $13
Sep-13-17Reiterated Needham Buy $17 → $15
Aug-31-17Resumed BTIG Research Buy $13
Jun-13-17Reiterated Needham Buy $16 → $17
Jan-24-17Reiterated Needham Buy $13 → $15
Feb-24-16Reiterated Needham Buy $13 → $11
Oct-28-15Reiterated Needham Buy $16 → $13
May-06-15Reiterated Canaccord Genuity Buy $16 → $14
Apr-17-15Reiterated Canaccord Genuity Buy $17 → $16
Dec-19-13Initiated Needham Buy $17
Aug-08-13Reiterated Canaccord Genuity Buy $18 → $14
Apr-15-13Reiterated Canaccord Genuity Buy $14 → $18
Jan-15-13Reiterated Canaccord Genuity Buy $12 → $14
Jan-13-20 07:00AM  GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019 GlobeNewswire -5.92%
Jan-06-20 07:25AM  Investors Who Bought GenMark Diagnostics (NASDAQ:GNMK) Shares Five Years Ago Are Now Down 64% Simply Wall St.
Jan-01-20 12:14PM  Penny Stocks to Buy Using Technical Analysis for January 2020 Investopedia
Dec-31-19 07:57AM  Penny Stocks to Watch for January 2020 Investopedia
Dec-30-19 04:05PM  GenMark Diagnostics to Participate in the J.P. Morgan Healthcare Conference GlobeNewswire
Dec-12-19 09:07PM  Edited Transcript of GNMK earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
07:38PM  Hedge Funds Have Never Been This Bullish On GenMark Diagnostics, Inc (GNMK) Insider Monkey
Nov-13-19 04:05PM  GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-07-19 07:22AM  Why GenMark Diagnostics, Inc. (NASDAQ:GNMK) Could Be Worth Watching Simply Wall St.
Nov-06-19 06:45PM  GenMark Diagnostics (GNMK) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:03PM  GenMark Diagnostics Reports Third Quarter 2019 Results GlobeNewswire
Nov-01-19 12:15PM  Hedge Funds Have Never Been More Bullish On GenMark Diagnostics, Inc (GNMK) Insider Monkey
Oct-30-19 10:34AM  GenMark Diagnostics (GNMK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-23-19 04:05PM  GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019 GlobeNewswire
Oct-12-19 10:47AM  Calculating The Fair Value Of GenMark Diagnostics, Inc. (NASDAQ:GNMK) Simply Wall St.
Sep-16-19 09:12AM  Would GenMark Diagnostics (NASDAQ:GNMK) Might Be Better Off With Less Debt Simply Wall St.
Aug-30-19 02:20AM  Edited Transcript of GNMK earnings conference call or presentation 5-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-19-19 11:08AM  Before You Buy GenMark Diagnostics, Inc. (NASDAQ:GNMK), Consider Its Volatility Simply Wall St.
Aug-05-19 09:23PM  GenMark Diagnostics Inc (GNMK) Q2 2019 Earnings Call Transcript Motley Fool
07:25PM  GenMark Diagnostics (GNMK) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  GenMark Diagnostics Reports Second Quarter 2019 Results GlobeNewswire
Jul-29-19 10:34AM  Will GenMark Diagnostics (GNMK) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-25-19 04:05PM  GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference GlobeNewswire
Jul-22-19 04:05PM  GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019 GlobeNewswire
10:31AM  Will GenMark Diagnostics (GNMK) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-19-19 02:34PM  Should You Worry About GenMark Diagnostics, Inc.'s (NASDAQ:GNMK) CEO Salary Level? Simply Wall St.
Jul-05-19 12:25PM  Hedge Funds Have Never Been This Bullish On GenMark Diagnostics, Inc (GNMK) Insider Monkey
May-28-19 07:52PM  Edited Transcript of GNMK earnings conference call or presentation 30-Apr-19 8:30pm GMT Thomson Reuters StreetEvents
May-23-19 04:05PM  GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire
May-01-19 04:05PM  GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference GlobeNewswire +7.18%
Apr-30-19 10:12PM  GenMark Diagnostics Inc (GNMK) Q1 2019 Earnings Call Transcript Motley Fool
05:41PM  GenMark Diagnostics: 1Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports First Quarter 2019 Results GlobeNewswire
04:02PM  GenMark Diagnostics Expands Commercial Team GlobeNewswire
Apr-24-19 09:20AM  Is GenMark Diagnostics, Inc. (NASDAQ:GNMK) Potentially Undervalued? Simply Wall St.
Apr-23-19 10:32AM  GenMark Diagnostics (GNMK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks
Apr-15-19 07:45AM  GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019 GlobeNewswire
07:30AM  GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel GlobeNewswire
Apr-01-19 01:25PM  GenMark Diagnostics (NASDAQ:GNMK) Shareholders Booked A 38% Gain In The Last Year Simply Wall St.
Mar-08-19 08:14AM  Does The GenMark Diagnostics, Inc. (NASDAQ:GNMK) Share Price Tend To Follow The Market? Simply Wall St.
Mar-01-19 06:23AM  Edited Transcript of GNMK earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-25-19 10:48PM  GenMark Diagnostics Inc (GNMK) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-21-19 08:54PM  GenMark Diagnostics Inc (GNMK) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:25PM  GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:38PM  GenMark Diagnostics: 4Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results GlobeNewswire
04:03PM  GenMark Diagnostics Announces Expansion of Executive Leadership Team GlobeNewswire
Feb-20-19 04:55PM  GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire +7.51%
Feb-14-19 10:31AM  Will GenMark Diagnostics (GNMK) Report Negative Earnings Next Week? What You Should Know Zacks
Feb-13-19 02:20PM  How Much Are GenMark Diagnostics, Inc. (NASDAQ:GNMK) Insiders Taking Off The Table? Simply Wall St.
Feb-07-19 04:43PM  GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019 GlobeNewswire
Feb-01-19 11:30AM  LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE -5.87%
Jan-30-19 07:25AM  New Research Coverage Highlights Cummins, R.R. Donnelley & Sons, James River Group, HNI, GenMark Diagnostics, and EP Energy Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-08-19 02:00PM  Should You Worry About GenMark Diagnostics, Inc.s (NASDAQ:GNMK) CEO Pay Cheque? Simply Wall St. +10.15%
08:00AM  GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018 GlobeNewswire
Dec-27-18 10:24AM  GenMark Bulls Emboldened By Accelerated ePlex Panel Clearance Benzinga +5.01%
Dec-26-18 08:00AM  GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel GlobeNewswire +14.62%
Dec-23-18 01:15AM  Is GenMark Diagnostics, Inc (GNMK) A Good Stock To Buy? Insider Monkey
Dec-20-18 02:15PM  GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel GlobeNewswire
Dec-19-18 05:22PM  GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Nov-29-18 10:39AM  How Financially Strong Is GenMark Diagnostics Inc (NASDAQ:GNMK)? Simply Wall St.
Nov-07-18 04:05PM  GenMark Diagnostics to Present at Upcoming Investor Conferences GlobeNewswire +9.73%
Nov-06-18 07:50AM  Analysis: Positioning to Benefit within Hess Midstream Partners LP, Quanta Services, ServiceSource International, Meritor, Donegal Group, and GenMark Diagnostics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -6.75%
Nov-01-18 11:06AM  Edited Transcript of GNMK earnings conference call or presentation 29-Oct-18 8:30pm GMT Thomson Reuters StreetEvents -5.25%
Oct-29-18 06:35PM  GenMark Diagnostics (GNMK) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:29PM  GenMark Diagnostics: 3Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports Third Quarter 2018 Results GlobeNewswire
Oct-15-18 04:05PM  GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018 GlobeNewswire
11:28AM  GenMark Diagnostics Inc (NASDAQ:GNMK): Cash Is King Simply Wall St.
09:25AM  Analysis: Positioning to Benefit within PTC, H&R Block, GenMark Diagnostics, American International Group, Newmont Mining, and Stryker Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-02-18 04:14PM  GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels GlobeNewswire
Sep-07-18 08:28AM  Is GenMark Diagnostics Inc (NASDAQ:GNMK) An Industry Laggard Or Leader? Simply Wall St.
Aug-23-18 05:45PM  Edited Transcript of GNMK earnings conference call or presentation 30-Jul-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-13-18 08:30AM  Recent Analysis Shows SUPERVALU INC, GenMark Diagnostics, E.W. Scripps, Cooper Tire & Rubber, Nexstar Broadcasting Group, and Cloud Peak Energy Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jul-30-18 06:35PM  GenMark Diagnostics (GNMK) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:29PM  GenMark Diagnostics: 2Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports Second Quarter 2018 Results GlobeNewswire
02:30PM  GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Jul-25-18 04:03PM  GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference GlobeNewswire
Jul-16-18 05:31PM  GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018 GlobeNewswire
Jun-28-18 04:57PM  GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel GlobeNewswire -5.26%
Jun-21-18 10:41AM  GenMark Diagnostics Inc (NASDAQ:GNMK): Does The -15.12% Earnings Drop Reflect A Longer Term Trend? Simply Wall St.
Jun-06-18 08:00AM  GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference GlobeNewswire
May-25-18 07:13AM  GenMark Diagnostics Inc (NASDAQ:GNMK): Is Breakeven Near? Simply Wall St.
May-14-18 08:15AM  Analysis: Positioning to Benefit within Cirrus Logic, Aaron's, Waste Connections, Shake Shack, R.R. Donnelley & Sons, and GenMark Diagnostics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-02-18 04:03PM  GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference GlobeNewswire +7.21%
May-01-18 07:47PM  Edited Transcript of GNMK earnings conference call or presentation 1-May-18 8:30pm GMT Thomson Reuters StreetEvents
05:32PM  GenMark Diagnostics: 1Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports First Quarter 2018 Results GlobeNewswire
Apr-17-18 04:03PM  GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018 GlobeNewswire
Apr-09-18 07:01PM  Cramer Remix: Ignoring Washington negatives could benefit... CNBC Videos
Mar-08-18 07:20AM  Blog Exposure - Zimmer Biomet Showcased New Product and Service Innovations at American Academy of Orthopaedic Surgeons Annual Meeting 2018 ACCESSWIRE
Mar-07-18 07:40AM  Free Post Earnings Research Report: Steris Revenues Grew 2%; Adjusted EPS Advanced 14% ACCESSWIRE
Feb-28-18 10:16AM  Edited Transcript of GNMK earnings conference call or presentation 27-Feb-18 9:30pm GMT Thomson Reuters StreetEvents -15.05%
Feb-27-18 07:11PM  GenMark Diagnostics reports 4Q loss Associated Press +7.06%
04:03PM  GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
12:40PM  GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-18 04:03PM  GenMark Diagnostics to Present at Upcoming Investor Conferences GlobeNewswire
Feb-13-18 04:03PM  GenMark Diagnostics Schedules Fourth Quarter and Full Year 2017 Financial Results Conference Call for February 27, 2018 GlobeNewswire
Feb-12-18 08:00AM  Research Report Identifies Waste Connections, Hercules Capital, Crown, GenMark Diagnostics, Clorox, and Cavium with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mitchell Brian AndrewSVP, OperationsJan 13Sale5.052,00010,100198,747Jan 14 04:50 PM
Gleeson MichaelSVP, Corp. AccountsNov 26Sale5.6020,099112,554329,417Nov 27 06:13 PM
McNally James B.SVP, Marketing and Bus. Dev.Nov 25Sale5.432,28812,424252,983Nov 26 05:05 PM
MASSARANY HANYPresident and CEONov 25Sale5.4316,42389,177776,045Nov 26 05:02 PM
Mendel ScottChief Operating OfficerNov 25Sale5.435,20628,269330,663Nov 26 04:59 PM
Ek John FrederickChief Financial OfficerNov 25Sale5.431,4207,711170,790Nov 26 04:57 PM
Jensen TylerSVP, Engineering and Tech DevNov 25Sale5.431,1366,168131,302Nov 26 04:54 PM
Stier EricSVP & General CounselNov 25Sale5.432,52213,694229,136Nov 26 04:51 PM
Gleeson MichaelSVP, Corp. AccountsNov 25Sale5.432,72814,813349,516Nov 26 04:50 PM
Mitchell Brian AndrewSVP, OperationsNov 25Sale5.431,95910,637200,747Nov 26 04:47 PM
Stier EricSVP & General CounselNov 20Sale5.551,6339,063231,658Nov 21 05:07 PM
Jensen TylerSVP, Engineering and Tech DevNov 20Sale5.553061,698132,438Nov 21 05:00 PM
MASSARANY HANYPresident and CEONov 20Sale5.557,74442,979792,468Nov 21 04:54 PM
Mendel ScottChief Operating OfficerNov 20Sale5.552,70114,991335,869Nov 21 04:51 PM
Gleeson MichaelSVP, Corp. AccountsNov 20Sale5.551,7469,690352,244Nov 21 04:48 PM
Ek John FrederickChief Financial OfficerNov 20Sale5.554892,714172,210Nov 21 04:46 PM
Mitchell Brian AndrewSVP, OperationsNov 18Sale5.534402,433202,706Nov 19 04:49 PM
Winkler Sarah HollisVP, Human ResourcesNov 12Sale5.625,50030,91056,292Nov 12 05:22 PM
McNally James B.SVP, Marketing and Bus. Dev.Nov 05Sale5.689385,328255,271Nov 06 05:32 PM
Mitchell Brian AndrewSVP, OperationsNov 05Sale5.686603,749203,146Nov 06 05:30 PM
Winkler Sarah HollisVP, Human ResourcesOct 30Sale5.883,20818,86361,792Nov 01 04:34 PM
McNally James B.SVP, Marketing and Bus. Dev.Oct 30Sale5.881,71810,102256,209Nov 01 04:32 PM
Gleeson MichaelSVP, Corp. AccountsAug 27Sale6.032,76616,679353,990Aug 30 06:57 PM
Ek John FrederickChief Financial OfficerAug 27Sale6.031,4398,677172,699Aug 30 06:55 PM
Mendel ScottChief Operating OfficerAug 27Sale6.033,68522,221338,570Aug 30 06:41 PM
McNally James B.SVP, Marketing and Bus. Dev.Aug 27Sale6.032,29613,845257,927Aug 30 06:39 PM
Mitchell Brian AndrewSVP, OperationsAug 27Sale6.031,96611,855203,806Aug 30 06:18 PM
Jensen TylerSVP, Engineering and Tech DevAug 27Sale6.031,1486,922132,744Aug 30 06:16 PM
MASSARANY HANYPresident and CEOAug 27Sale6.0316,659100,454800,212Aug 30 07:02 PM
Stier EricSVP & General CounselAug 27Sale6.032,55815,425233,291Aug 30 06:59 PM
Gleeson MichaelSVP, Corp. AccountsAug 20Sale6.251,82111,381356,756Aug 21 05:06 PM
Ek John FrederickChief Financial OfficerAug 20Sale6.255103,188174,138Aug 21 05:04 PM
MASSARANY HANYPresident and CEOAug 20Sale6.258,08050,500816,871Aug 21 05:02 PM
Mendel ScottChief Operating OfficerAug 20Sale6.251,96712,294342,255Aug 21 04:57 PM
Stier EricSVP & General CounselAug 20Sale6.251,70310,644235,849Aug 21 04:56 PM
Jensen TylerSVP, Engineering and Tech DevAug 20Sale6.253191,994133,892Aug 21 04:54 PM
Mitchell Brian AndrewSVP, OperationsAug 19Sale6.554352,849205,772Aug 21 04:59 PM
OBOYLE KEVIN CDirectorAug 16Sale6.5116,150105,13785,962Aug 19 05:15 PM
OBOYLE KEVIN CDirectorAug 15Option Exercise6.0043,050258,300129,012Aug 19 05:15 PM
OBOYLE KEVIN CDirectorAug 15Sale6.512,20014,322102,112Aug 19 05:15 PM
McNally James B.SVP, Marketing and Bus. Dev.Aug 05Sale5.871,0065,905260,223Aug 08 12:40 PM
Mitchell Brian AndrewSVP, OperationsAug 05Sale5.877114,174206,207Aug 08 12:38 PM
Ek John FrederickChief Financial OfficerAug 05Sale5.871,89011,094174,648Aug 08 12:35 PM
Ek John FrederickChief Financial OfficerMay 30Sale6.609246,098176,538May 31 04:35 PM
Stier EricSVP & General CounselMay 30Sale6.601,56410,322237,552May 31 04:33 PM
Gleeson MichaelSVP, Corp. AccountsMay 30Sale6.601,72911,411358,577May 31 04:32 PM
McNally James B.SVP, Marketing and Bus. Dev.May 30Sale6.602,05713,576261,229May 31 04:30 PM
Mitchell Brian AndrewSVP, OperationsMay 30Sale6.601,72911,411206,918May 31 04:28 PM
Mendel ScottChief Operating OfficerMay 30Sale6.602,30415,206344,222May 31 04:27 PM
MASSARANY HANYPresident and CEOMay 30Sale6.6010,36968,435824,951May 31 04:24 PM
Jensen TylerSVP, Engineering and Tech DevMay 30Sale6.608255,445134,211May 31 04:23 PM
MASSARANY HANYPresident and CEOMay 24Sale6.626,24741,355835,320May 28 04:34 PM
Mitchell Brian AndrewSVP, OperationsMay 24Sale6.622311,529208,647May 28 04:32 PM
Stier EricSVP & General CounselMay 24Sale6.629866,527239,116May 28 04:27 PM
Mendel ScottChief Operating OfficerMay 24Sale6.621,3719,076346,526May 28 04:25 PM
Gleeson MichaelSVP, Corp. AccountsMay 24Sale6.621,0296,812360,306May 28 04:22 PM
McNally James B.SVP, Marketing and Bus. Dev.May 24Sale6.622311,529263,286May 28 04:39 PM
Jensen TylerSVP, Engineering and Tech DevMay 23Sale6.853132,144135,036May 24 04:17 PM
Ek John FrederickChief Financial OfficerMay 23Sale6.855013,432177,462May 24 04:15 PM
Mendel ScottChief Operating OfficerMay 21Sale6.831,90713,025347,897May 22 05:08 PM
Ek John FrederickChief Financial OfficerMay 21Sale6.834953,381177,963May 22 05:07 PM
MASSARANY HANYPresident and CEOMay 21Sale6.837,83753,527841,567May 22 05:05 PM
Gleeson MichaelSVP, Corp. AccountsMay 21Sale6.831,76612,062361,335May 22 05:01 PM
Jensen TylerSVP, Engineering and Tech DevMay 21Sale6.833092,110135,349May 22 04:59 PM
Stier EricSVP & General CounselMay 21Sale6.831,65211,283240,102May 22 04:56 PM
Mitchell Brian AndrewSVP, OperationsMay 17Sale7.014483,140208,878May 20 04:52 PM
Gleeson MichaelSVP, Corp. AccountsMay 06Sale8.0010,00080,000363,101May 07 04:34 PM
Mitchell Brian AndrewSVP, OperationsMay 03Sale7.796545,095209,326May 06 04:40 PM
McNally James B.SVP, Sales and MarketingMay 03Sale7.799287,229263,517May 06 04:34 PM
Gleeson MichaelSVP, Corp. AccountsApr 15Sale7.5110,00075,100373,101Apr 16 04:26 PM
Gleeson MichaelSVP, Corp. AccountsFeb 28Sale7.8418,464144,758383,101Mar 01 05:58 PM
Gleeson MichaelSVP, Corp. AccountsFeb 27Sale7.9626,704212,564401,565Mar 01 05:58 PM
Stier EricSVP & General CounselFeb 25Sale6.8011,24376,452241,754Feb 27 04:38 PM
MASSARANY HANYPresident and CEOFeb 25Sale6.7954,596370,707849,404Feb 27 04:37 PM
Ek John FrederickChief Financial OfficerFeb 25Sale6.795,20535,342178,458Feb 27 04:33 PM
Mitchell Brian AndrewSVP, OperationsFeb 25Sale6.7910,99674,663209,980Feb 27 04:30 PM
Mendel ScottChief Operating OfficerFeb 25Sale6.8011,41077,588349,804Feb 27 04:27 PM
McNally James B.SVP, Sales and MarketingFeb 25Sale6.7912,29783,497264,445Feb 27 04:15 PM
Gleeson MichaelSVP, Corp. AccountsFeb 25Sale6.7912,09782,139428,269Feb 27 04:12 PM
Ek John FrederickChief Financial OfficerFeb 20Sale6.165953,665183,663Feb 21 09:25 PM
Mendel ScottChief Operating OfficerFeb 20Sale6.162,06312,708361,214Feb 21 07:14 PM
Stier EricSVP & General CounselFeb 20Sale6.161,98612,234252,997Feb 21 07:10 PM
Gleeson MichaelSVP, Corp. AccountsFeb 20Sale6.162,12113,065440,366Feb 21 07:08 PM
MASSARANY HANYPresident and CEOFeb 20Sale6.165,56234,262904,000Feb 21 07:07 PM
Mitchell Brian AndrewSVP, OperationsFeb 19Sale6.325193,280220,976Feb 21 07:11 PM
Stier EricSVP & General CounselJan 23Sale5.903,59621,216183,733Jan 25 06:33 PM
McNally James B.SVP, Sales and MarketingJan 23Sale5.904,73027,907175,492Jan 25 06:28 PM
MASSARANY HANYPresident and CEOJan 23Sale5.9015,16689,479692,062Jan 25 06:25 PM
Gleeson MichaelSVP, Corp. AccountsJan 23Sale5.903,97423,447367,487Jan 25 06:21 PM
Mitchell Brian AndrewSVP, OperationsJan 23Sale5.903,97423,447146,495Jan 25 06:18 PM
Mendel ScottChief Financial OfficerJan 23Sale5.905,29731,252235,777Jan 25 06:16 PM